| Application no. and date | 09744645.4 (espacenet) (Federated) (European Patent Register), 20091001 | | Patent/reg. no. and date | DK/EP 2342233, 20140625 | | Publication date | 20110713 | | Priority no. and date | EP 08305631, 20081001, US 136772 P, 20081001, US 173743 P, 20090429 | | EP pub. no. and date |
EP 2342233 20110713 | | Effective date | | | Applicant/owner | Pierre Fabre Médicament, 45, Place Abel Gance
92100 Boulogne-Billancourt, FR | | Applicant ref. no. | P81405343DK00E | | Inventor | KLINGUER-HAMOUR, Christine, 73 route de chez Diossaz
Les Gottalles
F-74570 Groisy, FR,
GRENIR-CAUSSANEL, Véronique, 1 rue de la Vie de l'Orme
01430 Saint Martin du Fresne, FR | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | Anti-CXCR4-antistoffer og anvendelse deraf i behandling af cancer | | Int. application no. | EP2009062787 | | Int. publication no. | WO2010037831 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
